Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Latest Posted December 26, 2024
Blood Sugar Supplement Recalled Due to Undeclared Metformin and Glyburide
On December 16, 2024, Shoppers- Plaza recalled all lots of Fouzee Sugarlin Herbal Formula capsules because they were found to contain undeclared metformin and glyburide.
(See ConsumerLab’s article about supplements for lowering blood sugar.)
Glyburide and metformin are prescription drugs used to lower blood sugar and treat type 2 diabetes and these products in combination with certain medications can cause unsafe drops in blood sugar levels, or hypoglycemia, or lactic acidosis.
Fouzee Sugarlin Herbal Formula capsules (see product photos) were promoted for blood sugar support and were sold nationwide on various websites and possibly in some retail stores. They can be further identified by the following:
- Product name: Fouzee Sugarlin Herbal Formula
- Packaging: White bottle containing 180 capsules
- UPC: 26656690477
Consumers should immediately stop using these products and seek medical attention, especially if they are currently being treated with diabetes drugs, have chronic kidney disease, or if they have symptoms of fatigue, body aches, abdominal pain, excessive hunger, profuse sweating, or numbness of the extremities.
Consumers and healthcare providers can report any adverse reactions to the FDA’s MedWatch Voluntary Reporting Program.
Shoppers Plaza is notifying distributors and customers by email, its website, and social media and is arranging for return of all recalled products.
For more information, use the link below.
See related recalls and warnings:
FDA Warns Seller of Diabetes Supplement Marketed with Rx Claims
Other Recent Recalls & Warnings
For information about reporting serious reactions and problems with medical products to the U.S. Food and Drug Administration through its MedWatch reporting program, please visit the FDA MedWatch website.